Home › NDC Lookup › Ingredients › Zinc Oxide › 11527-0058-41
Dr. Sheffield Diaper Rash Zinc Oxide 400 mg/g Ointment — NDC 11527-0058-41 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Dr. Sheffield Diaper Rash Zinc Oxide 400 mg/g Ointment — NDC 11527-058-41 (Billing 11527-0058-41)

by Sheffield Pharmaceuticals LLC · 1 TUBE in 1 CARTON / 56 g in 1 TUBE

This is a package of Dr. Sheffield Diaper Rash Zinc Oxide 400 mg/g Ointment from Sheffield Pharmaceuticals LLC, marketed since Jan 2002 and currently FDA-listed.

NDC 11527-0058-41
🏷️ FDA NDC (as labeled) 11527-058-41 billing pads the product segment with a zero
This package
Contains56 g in 1 tube Pack sizes2 compare ↓
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
⚠️
Other active recalls for Zinc Oxide (different manufacturers) — 6 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Oct 31, 2025 — cGMP deviations (Blossom Pharmaceuticals) · FDA recall D-0212-2026
Class II · Oct 31, 2025 — cGMP deviations (Blossom Pharmaceuticals) · FDA recall D-0206-2026
Class II · Oct 31, 2025 — cGMP deviations (Blossom Pharmaceuticals) · FDA recall D-0202-2026
Class II · Oct 31, 2025 — cGMP deviations (Blossom Pharmaceuticals) · FDA recall D-0207-2026
Class II · Oct 31, 2025 — cGMP deviations (Blossom Pharmaceuticals) · FDA recall D-0209-2026
Class II · Oct 31, 2025 — cGMP deviations (Blossom Pharmaceuticals) · FDA recall D-0208-2026
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 11527-058-41
Product NDC 11527-058
11-digit billing NDC 11527005841
NCPDP billing unit GM — per gram (weight)
RxCUI 244638
UNII SOI2LOH54Z
Application # M016
SPL Set ID cac77320-b5cf-4edf-9693-ebabfb61390c
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2002-01-09
Route TOPICAL
Dosage form OINTMENT
Substance ZINC OXIDE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GCN Seq No 015235
GCN 22083
HICL code 002361
Ingredient (HICL) Zinc Oxide
HIC1 code L
Therapeutic class — broad (HIC1) Skin/Subcutaneous Tissue
HIC2 code L3
Therapeutic class — intermediate (HIC2) Protectives
HIC3 code L3A
Therapeutic class — specific (HIC3) Protectives
AHFS code 84:24.12.00
AHFS class Basic Ointments And Protectants
FDB label name DIAPER RASH 40% OINTMENT
FDB brand name Diaper Rash
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 015235
  • GCN: 22083
  • HICL (First Databank): 002361
  • AHFS class code: 84:24.12.00
  • RxCUI (RxNorm): 244638
Why two NDCs? The FDA registers this code as 11527-058-41 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 11527-0058-41. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

Label name DIAPER RASH 40% OINTMENT Ingredient Zinc Oxide
🧪 What is this product?

Dr. Sheffield Diaper Rash is a topical ointment containing zinc oxide, an ingredient commonly used in diaper rash products. Zinc oxide functions as a barrier on the skin and is typically included in over-the-counter formulations meant to help manage minor diaper irritation. This is an OTC monograph drug, meaning it is marketed under FDA's established rules for this category of product rather than through individual product approval.

Supplement & herbal interactions

Some supplements/herbs that may interact with Zinc oxide (OTC drug) — tap one for details:

Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 28 g
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
11527-0058-40 11527-058-40 Main listing 1 TUBE in 1 CARTON / 28 g in 1 TUBE 2014-01-17 — Active
11527-0058-41 You're viewing this 1 TUBE in 1 CARTON / 56 g in 1 TUBE 2002-01-09 — Active

Pack size FAQ

What quantity is in this package?
This package is listed by the FDA — 1 tube in 1 carton / 56 g in 1 tube.
What NDC number is used to bill for this package of Dr. Sheffield Diaper Rash Zinc Oxide 400 mg/g Ointment?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Zinc Oxide 40% 40 g/100g 70000-0469-01 Cardinal 1 tube $0.034 — Availability likely —
Dr. Sheffield Diaper Rash 400 mg/gthis 11527-0058-41 Sheffield 1 tube — — FDA listed —
Zinc Oxide 400 mg/g 11822-0534-01 Rite 1 tube — — FDA listed —
Burts Bees Baby Bee Diaper Rash 40 g/100g 26052-0028-01 BURT'S 85 g — — FDA listed —
Diaper Rash 400 mg/g 30142-0020-26 The 1 tube — — FDA listed —
Diaper Rash 400 mg/g 41163-0020-26 United 1 tube — — FDA listed —
Diaper Rash 400 mg/g 49035-0952-26 Walmart 1 tube — — FDA listed —
Diaper Rash 400 mg/g 67091-0020-26 WinCo 1 tube — — FDA listed —
Natureplex Diaper Rash 400 mg/g 67234-0001-01 Natureplex 1 tube — — FDA listed —
DiaperRashOintment 40 g/100g 68016-0128-20 Pharmacy 113 g — — FDA listed —
Best Choice Diaper Rash 40 g/100g 69396-0152-01 Trifecta 113 g — — FDA listed —
CVS Health Diaper Rash 400 mg/g 69842-0058-20 CVS 1 tube — — FDA listed —
Zinc Oxide 400 mg/g 72288-0989-26 Amazon.com 1 tube — — FDA listed —
Vitacilina Bebe Diaper Rash 400 mg/g 81929-0002-01 Taisho 1 tube — — FDA listed —
Quality Choice Diaper Rash 40 g/100g 83324-0042-01 Chain 113 g — — FDA listed —
Diaper Rash 40 g/100g 87236-0018-04 Aldermed 113 g — — FDA listed —
Walgreens Maximum Diaper Rash 400 mg/g 00363-7280-20 Walgreens 1 tube — — FDA listed —
Desitin Maximum Strength Zinc Oxide Diaper Rash 400 mg/g 69968-0768-01 Kenvue 1 tube — — FDA listed —
Diaper Rash 400 mg/g 41250-0412-26 Meijer, 1 tube — — FDA listed —
Baby Diaper Rash Cream 400 mg/g 73418-0301-01 Hello 1 tube — — FDA listed —
Diaper Rash 400 mg/g 11344-0020-26 Nice-Pak 1 tube — — FDA listed —
Zinc Oxide 400 mg/g 69842-0468-26 CVS 1 tube — — FDA listed —
Desitin Maximum Strength Diaper Rash 400 mg/g 69968-0061-01 Kenvue 1 tube — — FDA listed —
Diaper Rash 400 mg/g 36800-0020-26 Topco 1 tube — — FDA listed —
Zinc Oxide 400 mg/g 00363-1020-26 Walgreen 1 tube — — FDA listed —
Desitin Maximum Strength Zinc Oxide Diaper Rash 400 mg/g 69968-0396-01 Kenvue 454 g — — FDA listed —
Desitin Maximum Strength Zinc Oxide Diaper Rash 400 mg/g 69968-0848-01 Kenvue 454 g — — FDA listed —
Diaper Rash 400 mg/g 11673-0020-26 Target 1 tube — — Discontinued —
Diaper Rash 400 mg/g 37808-0020-26 H 1 tube — — FDA listed —
Diaper Rash 400 mg/g 55910-0020-26 Old 1 tube — — FDA listed —
Zinc Oxide 400 mg/g 72476-0920-26 ADUSA 1 tube — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2002
On the market since
Jan 2002
📍
2026
Currently FDA-listed
24 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerSheffield Pharmaceuticals LLC
FDA applicationM016 (OTC MONOGRAPH DRUG)
Labeler code11527
First marketedJan 2002
Product typeHuman Otc Drug
Portfolio29 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 19 words ▾

Uses helps treat and prevent diaper rash protects chafed skin due to diaper rash and helps seal out wetness

⏱️ Dosage and Administration 39 words ▾

Directions change wet and soiled diapers promptly cleanse the diaper area, and allow to dry apply ointment liberally as often as necessary, with each diaper change, especially at bedtime or anytime when exposure to wet diapers may be prolonged

⚠️ Warnings 57 words ▾

Warnings For external use only When using this product avoid contact with eyes Stop use and ask a doctor if condition worsens symptoms last more than 7 days or clear up and occur again within a few days Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

🧪 Active Ingredient 5 words ▾

Active ingredient Zinc Oxide 40%

🧪 Inactive Ingredients 11 words ▾

Inactive ingredients BHA, Cod liver oil, Fragrance, Lanolin, Petrolatum, Talc, Water

🎯 Purpose 3 words ▾

Purpose Skin protectant

📄 When Using This Product 8 words ▾

When using this product avoid contact with eyes

📄 Stop Use and Ask a Doctor If 25 words ▾

Stop use and ask a doctor if condition worsens symptoms last more than 7 days or clear up and occur again within a few days

📄 Keep Out of Reach of Children 19 words ▾

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

📄 Other Information 12 words ▾

Other information store at room temperature 15° - 30°C (59° - 86°F)

📄 Package Label / Principal Display Panel 87 words ▾

Principal Display Panel - Carton Label NDC 11527-058-41 Dr. Sheffield's Made in the USA Diaper Rash Ointment 40% Zinc Oxide Skin Protectant • Promotes healing • Relieves chafing • Paraben free Helps Treat and Prevent Diaper Rash NET WT. 2 oz. (56g) Principal Display Panel - Carton Label

Principal Display Panel - Tube Label NDC 11527-058-41 Dr. Sheffield's Made in the USA Diaper Rash Ointment NET WT. 2 oz. (56g) 40% Zinc Oxide Skin Protectant Helps Treat and Prevent Diaper Rash Principal Display Panel - Tube Label

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Dr. Sheffield Diaper Rash (this brand).

Top reported reactions

Macular Degeneration460
Pyrexia306
Nausea290
Pain282
Malaise261
Weight Decreased236
Therapeutic Product Effect Incomplete214

Age at onset

Neonate5
Infant8
Child28
Adolescent5
Adult110
Elderly192

Reporter sex

1,941 reports
Male · 37%
Female · 63%
Unknown · 0%

Serious outcomes

Hospitalization988
Death204
Life-threatening116
Disabling32
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 272 82
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Sheffield Pharmaceuticals LLC. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 1 other package presentation of this same product, including 1 tube (11527-0058-40). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Sheffield Pharmaceuticals LLC is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.